| Literature DB >> 35733434 |
Shanna D Kulik1, Ilse M Nauta2, Prejaas Tewarie2,3, Ismail Koubiyr4, Edwin van Dellen5, Aurelie Ruet4,6, Kim A Meijer1, Brigit A de Jong2, Cornelis J Stam2,3, Arjan Hillebrand3, Jeroen J G Geurts1, Linda Douw1, Menno M Schoonheim1.
Abstract
Multiple sclerosis (MS) features extensive connectivity changes, but how structural and functional connectivity relate, and whether this relation could be a useful biomarker for cognitive impairment in MS is unclear. This study included 79 MS patients and 40 healthy controls (HCs). Patients were classified as cognitively impaired (CI) or cognitively preserved (CP). Structural connectivity was determined using diffusion MRI and functional connectivity using resting-state magnetoencephalography (MEG) data (theta, alpha1, and alpha2 bands). Structure-function coupling was assessed by correlating modalities, and further explored in frequency bands that significantly correlated with whole-brain structural connectivity. Functional correlates of short- and long-range structural connections (based on tract length) were then specifically assessed. Receiving operating curve analyses were performed on coupling values to identify biomarker potential. Only the theta band showed significant correlations between whole-brain structural and functional connectivity (rho = -0.26, p = 0.023, only in MS). Long-range structure-function coupling was stronger in CI patients compared to HCs (p = 0.005). Short-range coupling showed no group differences. Structure-function coupling was not a significant classifier of cognitive impairment for any tract length (short-range area under the curve (AUC) = 0.498, p = 0.976, long-range AUC = 0.611, p = 0.095). Long-range structure-function coupling was stronger in CI MS compared to HCs, but more research is needed to further explore this measure as biomarkers in MS.Entities:
Keywords: Cognition; Diffusion tensor imaging; Functional connectivity; Magnetoencephalography; Multiple sclerosis; Structural connectivity
Year: 2022 PMID: 35733434 PMCID: PMC9208024 DOI: 10.1162/netn_a_00226
Source DB: PubMed Journal: Netw Neurosci ISSN: 2472-1751
Demographic, clinical, cognitive, and MRI outcomes of MS patients and healthy controls
| Healthy Controls | MS Patients | |||
|---|---|---|---|---|
| Total Group | CP Patients | CI Patients | ||
|
| ||||
| Age; years, mean ( | 50.7 (6.11) | 53.8 (10.7) | 53.4 (10.8) | 54.3 (10.8) |
| Sex; % females | 63% | 72% | 74% | 70% |
| Education; % low/high | 40/60% | 50/50% | 46/54% | 56/44% |
|
| ||||
| Disease duration; years, mean ( | n/a | 18.1 (6.93) | 18.0 (6.77) | 18.3 (7.3) |
| MS type; RR/SP/PP (%) | n/a | 71/20/9% | 76/17/7% | 64/24/12% |
| EDSS; median (range) | n/a | 3.50 (1–8) | 3.25 (1–8) | 4.00 (2.5–7.5) |
|
| ||||
| Cortical gray matter volume; L, mean ( | 0.764 (0.033) | 0.732 (0.050) | 0.740 (0.047) | 0.721 (0.052) |
| Deep gray mater volume; mL, mean ( | 61.5 (2.71) | 54.2 (7.00) | 56.4 (5.58) | 51.3 (7.62) |
| White matter lesion load; mL, median (range) | n/a | 12.6 (2.47–85.5) | 11.0 (3.17–61.0) | 18.7 (2.47–85.5) |
Note. Disease duration represents the disease duration since symptom onset. CI = cognitively impaired; CP = cognitively preserved; EDSS = Expanded Disability Status Scale; MS = multiple sclerosis; n/a = not applicable; PP = primary progressive; SD = standard deviation; RR = relapsing remitting; SP = secondary progressive.
Significantly different from MS patients (p < 0.05).
Overview of the applied methods to calculate structure-function relationships. (A) Schematic representation of SC and FC. (B) Between-subject correlations were calculated by first averaging all connections in the upper triangle of each individual subject’s matrix for both SC (blue M) and FC (orange M). Subsequently, these averaged values for SC and FC were correlated across subjects within the HC and MS groups separately. (C) Within-subject correlations were calculated by first vectorizing all short- and long-range connections (see panel D) in the upper triangle of each subject’s matrix for both SC and FC. Second, these SC and FC vectors were correlated within each subject to determine structure-function coupling. (D) Schematic representation of short- (Q1) and long-range (Q4) connections, based on the first and fourth quartiles of the histogram of tract lengths in HCs. SC = structural connectivity; FC = functional connectivity; M = mean, Q1 = first quartile; Q4 = fourth quartile.
Distribution of tract lengths in healthy controls. Structural connections of both HCs and MS patients were categorized into short-range (<96.765 mm) and long-range connections (>172.056 mm) based on first and fourth quartile thresholds. Q1 = first quartile; Q2 = second quartile; Q3 = third quartile; Q4 = fourth quartile.
Between-subject correlations: the relationship between FC theta and SC in MS. (A) Relation between whole-brain SC and FC (r = −0.256, p = 0.023). (B) Relation between average long-range SC and FC (r = −0.248, p = 0.028). (C) Relation between average short-range SC and FC (r = −0.313, p = 0.005). SC = structural connectivity; FC = functional connectivity.
The structure-function coupling for long-range connections within the different groups. Each dot denotes a participant. Boxplots show the median value per group; *p < 0.05. HC = healthy controls; CP = cognitively preserved MS patients; CI = cognitively impaired MS patients.
SC and FC of long-range connections across groups. Each dot denotes a participant. Boxplots show the median value per group. (A) SC of long-range connections per group. (B) FC of long-range connections per group. *p < 0.05. SC = structural connectivity; FC = functional connectivity; HC = healthy controls; CP = cognitively preserved MS patients; CI = cognitively impaired MS patients.
Between-subject correlations for short- and long-range connections
| MS | HC | |
|---|---|---|
| Short-range alpha1 | ||
| Short-range alpha2 | ||
| Long-range alpha1 | ||
| Long-rang alpha2 |